Reboxetine Meta-Analysis Calls Into Question Veracity of All Industry-Sponsored Research

The recent meta-analysis in the British Medical Journal says Reboxetine is "ineffective and potentially harmful".  Publication bias evident.

http://www.ncbi.nlm.nih.gov/pubmed/20940209

http://www.medscape.com/viewarticle/730537

Posted via email from nocx